Asia Pacific has been the fastest growing region in Phase I trials in the last ten years, reaching a share of 58% in 2022, with China leading the Phase I trials globally.
Novotech Sponsors BIO 2023 APAC Summit and the Endpoints Panel on Forging Biotech Ties with China
Boston, MA - USA - Novotech, the leading Asia Pacific centred b
Read more